Concepedia

Bettina Danner

BD

Statistics

Publications

5

Citations

268

H-Index

5

Active since

2005

Affiliations

University Hospital Ulm(Current)

Royal Liverpool University Hospital

Fondazione IRCCS Istituto Nazionale dei Tumori

Memorial Sloan Kettering Cancer Center

The Netherlands Cancer Institute

Bettina Danner is an author at University Hospital Ulm specializing in medicine, cancer therapeutics, and radiation oncology.

Top concepts

Publications per year

2005–2016

5

Publications

5

The impact of economic progress and modernization in medicine on the ossification of hand and wrist

Andreas Schmeling, Ronald Schulz, Bettina Danner et al. · International Journal of Legal Medicine · 2005 · 179 citations

, , +10

p16 Expression Differentiates High-Risk Gastrointestinal Stromal Tumor and Predicts Poor Outcome

Michael Schmieder, Sebastian Wolf, Bettina Danner et al. · Neoplasia · 2008 · 37 citations · Full text

Atezolizumab (atezo) in platinum (plat)-treated locally advanced/metastatic urothelial carcinoma (mUC): Updated OS, safety and biomarkers from the Ph II IMvigor210 study

Yohann Loriot, Jonathan E. Rosenberg, Tom Powles et al. · Annals of Oncology · 2016 · 24 citations

, , +6

DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma

Thomas J. Ettrich, Lukas Perkhofer, Goetz von Wichert et al. · BMC Cancer · 2016 · 18 citations · Full text

IMvigor210: updated analyses of first-line (1L) atezolizumab (atezo) in cisplatin (cis)-ineligible locally advanced/metastatic urothelial carcinoma (mUC)

Joaquim Bellmunt, Arjun Vasant Balar, Matthew D. Galsky et al. · Annals of Oncology · 2016 · 10 citations · Full text

, , +8

1–5 of 5